albumin novo nordisk injectable solution 50 mg/ml
wael pharmacy - human serum albuminum (125 i) - injectable solution - 50
albumin novo nordisk injectable solution 50 mg/ml
wael pharmacy - human serum albuminum (125 i) - injectable solution - 50
albumin novo nordisk injectable solution 200 mg/ml (20%)
wael pharmacy - human serum albuminum (125 i) - injectable solution - 200
albumin novo nordisk injectable solution 200 mg/ml (20%)
wael pharmacy - human serum albuminum (125 i) - injectable solution - 200
albumin (human)- albumin human solution
octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 200 g in 1000 ml - albumin (human) 20% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 20% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 20% will be temporary unless the underlying disorder is reversed. albumin (human) 20% may be used to maintain cardiovascular function following the removal of large volumes of ascitic f
albumin (human)- albumin human solution
octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 250 g in 1000 ml - albumin (human) 25% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 25% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 25% will be temporary unless the underlying disorder is reversed. albumin (human) 25% may be used to maintain cardiovascular function following the removal of large volumes of ascitic
albumin (human)- albumin human solution
octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 50 g in 1000 ml - albumin (human) 5% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] albumin (human) 5% should be used when hydration is not adequate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 5% infusions may be indicated.[ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 5% will be temporary unless the underlying disorder is reversed. albumin (human) 5% may be used to maintain cardiovascular
albumin (human)- albumin human solution
octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 50 g in 1000 ml - albumin (human) 5% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] albumin (human) 5% should be used when hydration is not adequate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 5% infusions may be indicated.[ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 5% will be temporary unless the underlying disorder is reversed. albumin (human) 5% may be used to maintain cardiovascular fu
albumin (human)- albumin human solution
octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 200 g in 1000 ml - albumin (human) 20% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 20% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 20% will be temporary unless the underlying disorder is reversed. albumin (human) 20% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui
albumin (human)- albumin human solution
octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 250 g in 1000 ml - albumin (human) 25% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 25% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 25% will be temporary unless the underlying disorder is reversed. albumin (human) 25% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui